Att 2A Published 60d FRN

13056

Federal Register / Vol. 79, No. 45 / Friday, March 7, 2014 / Notices

burden is the specific request for a
clinical abstract of terminal illness and
final diagnosis relating to
pneumoconiosis. Therefore, only five
minutes of additional burden is
estimated for the pathologist’s report.

• Consent, Release and History Form
(2.6)—This form documents written
authorization from the next-of-kin to
perform an autopsy on the deceased
miner. A minimum of essential
information is collected regarding the
deceased miner including the

occupational history and smoking
history. From past experience, it is
estimated that 15 minutes is required for
the next-of-kin to complete this form.
There are no costs to respondents
other than their time.

ESTIMATED ANNUALIZED BURDEN HOURS
Form name

Coal Mine Operators .......................................
X-ray Facility Supervisor .................................
X-ray—Coal Miners .........................................
Coal Miners .....................................................
B Reader Physicians ......................................
Physicians taking the B Reader Examination
Spirometry Test—Coal Miners ........................
Pathologist ......................................................
Pathologist ......................................................
Next-of-kin for deceased miner ......................

Form 2.10 .......................................................
Form 2.11 .......................................................
No form required ............................................
Form 2.9 .........................................................
Form 2.8 .........................................................
Form 2.12 .......................................................
No form required ............................................
Invoice—No standard form ............................
Pathology Report—No standard form ............
Form 2.6 .........................................................

Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–04971 Filed 3–6–14; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[60Day–14–0904]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Leroy Richardson, 1600
Clifton Road, MS D–74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)

VerDate Mar<15>2010

18:39 Mar 06, 2014

Jkt 232001

ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project

Centers for Disease Control and
Prevention

mstockstill on DSK4VPTVN1PROD with NOTICES

Number of
respondents

Type of respondents

SEARCH for Diabetes in Youth Study
(OMB No. 0920–0904, exp. 11/30/
2014)—Revision—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Diabetes is one of the most common
chronic diseases among children in the
United States. When diabetes strikes
during childhood, it is routinely
assumed to be type 1, or juvenile-onset,
diabetes. Type 1 diabetes (T1D)
develops when the body’s immune
system destroys pancreatic cells that
make the hormone insulin. Type 2
diabetes begins when the body develops
a resistance to insulin and no longer
uses it properly. As the need for insulin
rises, the pancreas gradually loses its
ability to produce sufficient amounts of
insulin to regulate blood sugar. Reports
of increasing frequency of both type 1
and type 2 diabetes in youth have been
among the most concerning aspects of
the evolving diabetes epidemic. In
response to this growing public health
concern, the Centers for Disease Control
and Prevention (CDC) and the National

PO 00000

Frm 00022

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

200
100
5,000
5,000
10,000
100
2,500
5
5
5

1
1
1
1
1
1
1
1
1
1

Average
burden/
response
(in hrs)
30/60
30/60
15/60
20/60
3/60
10/60
20/60
5/60
5/60
15/60

Institutes of Health (NIH) funded the
SEARCH for Diabetes in Youth Study.
The SEARCH for Diabetes in Youth
Study began in 2000 as a multi-center,
epidemiological study, conducted in six
geographically dispersed clinical study
centers that reflected the racial and
ethnic diversity of the U.S. Phases 1
(2000–2005) and 2 (2005–2010)
produced estimates of the prevalence
and incidence of diabetes among youth
age <20 years, according to diabetes
type, age, sex, and race/ethnicity, and
characterized selected acute and chronic
complications of diabetes and their risk
factors, as well as the quality of life and
quality of health care. In Phases 1 and
2, the clinical centers and a data
coordinating center were funded
through cooperative agreements. The
information collected at that time was
not provided directly to CDC.
Phase 3 (2011–present) builds upon
previous efforts. Five clinical sites
collect patient-level information that is
compiled by a data coordinating center.
CDC obtained OMB approval to receive
the information in 2011 (SEARCH for
Diabetes in Youth, OMB No. 0920–0904,
exp. 11/30/2014). Phase 3 includes a
case registry of youth <20 years of age
who have been diagnosed with diabetes,
and a longitudinal cohort research study
about SEARCH cases whose diabetes
was incident in 2002 or later. To date,
SEARCH Phase 3 has identified an
average of 1,361 incident cases of
diabetes among youth under 20 years
each year of the study and has
completed an average of 1,088
participant surveys each year (80%
participation rate among registry study
participants). As of November 2013,

E:\FR\FM\07MRN1.SGM

07MRN1

13057

Federal Register / Vol. 79, No. 45 / Friday, March 7, 2014 / Notices
SEARCH Phase 3 has completed visits
for 1,839 cohort study participants.
CDC plans to continue information
collection for two additional years, with
minor changes. Participants in the
registry study will continue to complete
a Medication Inventory and an Initial
Participant Survey; however, the inperson study examination will be
discontinued. This change will result in
a decrease in burden per respondent.
CDC estimates that each clinical site
will identify and register an average of
255 cases per year, for a total 1,275
cases across all sites.
No data collection changes are
planned for the cohort study. CDC
estimates that each clinical site will

conduct follow-up on an average of 142
cases per year, for a total of 710 cases
across all sites. The items collected for
each case include a Health
Questionnaire (Youth version), an
additional Health Questionnaire (Parent
version), Center for Epidemiologic
Study-Depression, Quality of Care,
Pediatric Quality of Life Survey (Peds
QL), SEARCH Michigan Neuropathy
Screening Instrument, Diabetes Eating
Survey, Low Blood Sugar Survey,
Supplemental Survey, Tanner Stage,
Retinal Photo, Family Conflict Survey,
Pediatric Diabetes Quality of Life Scale,
Physical Exam, Specimen Collection,
and Food Frequency Questionnaire.

Findings from the registry study will
be used to estimate the incidence of
diabetes in youth in the U.S. Findings
from the cohort study will be used to
estimate the prevalence and incidence
of risk factors and complications
associated with diabetes in youth,
including chronic microvascular
complications (retinopathy,
nephropathy, and autonomic
neuropathy) and selected markers of
macrovascular complications
(hypertension, arterial stiffness) of
diabetes.
Participation is voluntary and there
are no costs to respondents other than
their time.

ESTIMATED ANNUALIZED BURDEN HOURS
Form name

SEARCH Registry Study Participants .....

Medication Inventory ..................
Initial Participant Survey ............
Health Questionnaire-Youth ......
Health Questionnaire-Parent .....
CES-Depression ........................
Quality of Care ...........................
Peds QL .....................................
SEARCH MNSI Neuropathy ......
Diabetes Eating Survey .............
Low Blood Sugar Survey ...........
Supplemental Survey .................
Tanner Stage .............................
Retinal Photo .............................
Family Conflict Survey ...............
Pediatric Diabetes QOL Scale ...
Physical Exam ...........................
Specimen Collection ..................
Food Frequency Questionnaire

1,275
1,275
710
710
710
710
710
710
710
710
710
710
710
710
710
710
710
710

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

5/60
10/60
15/60
15/60
4/60
13/60
5/60
10/60
5/60
5/60
10/60
5/60
15/60
5/60
5/60
3
20/60
20/60

106
213
178
178
47
154
59
118
59
59
118
59
178
59
59
2,130
237
237

....................................................

........................

........................

........................

4,248

SEARCH Cohort Study Participants .......

Total .................................................

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–04974 Filed 3–6–14; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[30Day–14–0138]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under

VerDate Mar<15>2010

18:39 Mar 06, 2014

Jkt 232001

Number of
respondents

review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project

Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES

Average
burden per
response
(in hr)

Number of
responses per
respondent

Type of
respondents

Pulmonary Function Testing Course
Approval Program, 29 CFR 1910.1043
(OMB No. 0920–0138, Expiration 8/31/
2014)—Revision—The National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).

PO 00000

Frm 00023

Fmt 4703

Sfmt 4703

Total burden
(in hr)

Background and Brief Description
NIOSH has the responsibility under
the Occupational Safety and Health
Administration’s Cotton Dust Standard,
29 CFR 1920.1043, for approving
courses to train technicians to perform
pulmonary function testing in the cotton
industry. Successful completion of a
NIOSH-approved course is mandatory
under the standard.
To carry out its responsibility, NIOSH
maintains a Pulmonary Function
Testing Course Approval Program. The
program consists of an application
submitted by potential sponsors
(universities, hospitals, and private
consulting firms) who seek NIOSH
approval to conduct courses, and if
approved, notification to NIOSH of any
course or faculty changes during the
approval period, which is limited to five
years. The application form and added
materials, including an agenda,

E:\FR\FM\07MRN1.SGM

07MRN1